• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$36.88 -$0.19 (-0.51%)

REAL-TIME: Last trade at

Medtronic, Inc.

NYSE:MDT

Medtronic reports fourth quarter growth

Senate passes FDA funding bill, Reuters reports

Plan to Speed Up FDA Reviews Will Look to Benefit Medical Devices Companies

Study results of Medtronics Resolute stent announced

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

Medtronic completes enrollment in blunt thoracic aortic injuries study

CFA of Minnesota hosts a conference

Groups resume normal succession planning

Medtronic Foundation Supports New Initiative to Develop National Plans Addressing Noncommunicable Diseases (NCDS)

Coffee Break: Medtronic earnings increase 28% in 4Q

International growth helps Medtronic beat estimates

Medtronic earnings up; 1,000 jobs -- 250 in Twini Cities -- to be cut

Why We Like Medtronic's Dividend Growth Profile

Facebook Overvalued Even After One of the Biggest IPO Busts Ever (RL, AZO, DSW, MDT, FB, TSCO, CHRM)

Medtronic’s Earnings Call

Medtronic CEO on Earnings

Feeling A Little Better About The Growth/Value Proposition At Medtronic

Medtronic Management Discusses Q4 2012 Results - Earnings Call Transcript

Medtronic fiscal 4Q profit climbs 28 pct

Medtronic Q4 Profit Jumped 28%

Medtronic Posts Mixed Numbers - Analyst Blog

Medtronic Posts Mixed Numbers

Medtronic - MDT - Improved revenue growth this qua..

Medtronic fiscal 4Q profit climbs 28 pct

Summer Reading List: The B-School Edition

Medtronic’s sales up 4% in Q4, earnings grow 28%

Medtronic earnings surge in fourth quarter

Medtronic Profit Beats Analyst Estimates on New Stent Demand

Biosensors - A Global Market Overview

Medtronic earnings, revenues top expectations

Medtronic reports strong fourth quarter profits

UPDATE: Medtronic 4Q Profit Rose 28% On Fewer Charges, Sales Growth

Pre-market Movers For May 22 (BBY, MDT, AZO, RL, BNHN, FB, EDGR)

Medtronic Tops View On Higher Emerging Market Sales

Medtronic sees FY13 gross margins 75.5%-76% ex-currency change

Medtronic sees INFUSE business continuing as headwind at least until Yale study

Medtronic says remains committed to returning 50% of free cash flow to holders

Medtronic sees maintaining or growing U.S. ICD share going forward

Medtronic 4Q Profit Rose 28% On Fewer Charges, Sales Growth

Medtronic CEO says in discussion with Aetna on potential partnerships

See More Articles...